See what questions
a doctor would ask.
Exenatide is waiting for approval by the FDA as an alternative diabetes drug for type 2 sufferers who don't respond well to sulfonylurea-type drugs. The drug also promotes weight loss. The drug works by imitating intestinal tract hormones that help regulate glucose levels. The main side effects of the drug are mild to moderate nausea during initial stages of treatment.
Source: summary of medical news story as reported by Reuters
About: Alternative drug for type 2 diabetes awaiting FDA approval
Date: 28 October 2004
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City